News Search Results
Feb 24, 2026, 07:30 ET BTQ Announces QPerfect and SDT Launch MIMIQ™-Powered Quantum Emulation Service on QUREKA™
conditions in the financial markets; changes in laws (including regulations respecting blockchains); risks related to the direct and indirect impact of COVID-19 including, but not limited to, its impact on general economic conditions, the ability to obtain financing as required, and causing potential delays
More news about: BTQ Technologies Corp.
Feb 24, 2026, 06:45 ET Life Time Reports Fourth Quarter and Full-Year 2025 Financial Results
to provide certain business interruption insurance coverage related to the government-ordered suspensions of our club operations in 2020 during the COVID-19 pandemic, representing payment of up to $1.0 million plus interest for 26 occurrences of 29 total occurrences found by the Minnesota Court of Appeals
More news about: Life Time Group Holdings, Inc.
Feb 24, 2026, 06:30 ET Xenia Hotels & Resorts Reports Fourth Quarter and Full Year 2025 Results
cyber-attacks, mass casualty events, government shutdowns and closures, travel-related health concerns, global outbreaks of pandemics (such as the COVID-19 pandemic) or contagious diseases, or fear of such outbreaks, weather and climate-related events, such as hurricanes, tornadoes, floods, wildfires,
More news about: Xenia Hotels & Resorts, Inc.
Feb 24, 2026, 01:33 ET Rapid and accurate method from VTT for detecting hormones, toxins and other small molecules
active role in their wellbeing.A concrete example of this is VTT's testosterone LFA test (lateral flow assay), a test platform familiar from COVID-19 home tests. In the design, the immunocomplex antibody is immobilised on a test strip, while its complementary testosterone binding antibody is conjugated
More news about: VTT Info
Feb 23, 2026, 11:15 ET Medical Scrubs Market to Reach $85.8 Billion, Globally, by 2033 at 5.9% CAGR: Allied Market Research
fuels the market growth. Scrubs act as a barrier against contaminants and reduce cross-infection risk. This focus increased significantly during the COVID-19 pandemic and continues as healthcare facilities enforce strict sanitary protocols.Rise in risk of hospital associated infections, surge in
More news about: Allied Market Research
Feb 23, 2026, 08:01 ET TransCode Therapeutics Announces Publication of Preclinical Testing of RIG-I Immunotherapeutic Candidate Supporting Further Development
similar uses; risks associated with TransCode's dependence on third parties; and risks associated with geopolitical events and pandemics, including the COVID-19 coronavirus and military actions. For a discussion of these and other risks and uncertainties, and other important factors, any of which could cause
More news about: TransCode Therapeutics, Inc.
Feb 23, 2026, 08:00 ET CONTANGO ORE, INC. ANNOUNCES FILING AND MAILING OF SPECIAL MEETING PROXY STATEMENT IN CONNECTION WITH THE PROPOSED PLAN OF ARRANGEMENT WITH DOLLY VARDEN
acquisitions; inability of our management team to execute its plans to meet its goals; the extent of disruptions caused by an outbreak of disease, such as the COVID-19 pandemic; and the possibility that government policies may change, political developments may occur or governmental approvals may be delayed or withheld,
More news about: Contango Ore
Feb 23, 2026, 07:30 ET NAPCO Security Technologies to Participate in Raymond James 47th Annual Institutional Investors Conference
trends, and anticipated product performance. These forward-looking statements include, but are not limited to, statements relating to the impact of COVID-19 pandemic; the growth of recurring service revenue and annual run rate; the introduction of new access control and locking products; the opportunities
More news about: NAPCO Security Technologies, Inc.
Feb 23, 2026, 00:15 ET Private equity resurgence gathers steam as new era challenges firms to enhance value creation--Bain & Company Global PE Report
while the total number of exits fell slightly to 1,570 – a 2% drop year-on-year that left exit count broadly in line with the level just before the Covid-19 pandemic.While exit activity was less pronounced across the broader market, exit value below the $10 billion threshold still grew by 34% as
More news about: Bain & Company
Feb 20, 2026, 17:38 ET The Inner Circle acknowledges, Scott Alexander Rose as a Pinnacle Achiever 2026
materials, and homework help, the library is making reading and learning fun and popular in Chajul. In 2021, its innovative approach to literacy during COVID-19 was honored with the UNESCO King Sejong Literacy Prize.To address the growing number of alumni and deepen its investment in the youth it serves,
More news about: The Inner Circle
Feb 20, 2026, 16:10 ET NaaS Technology Inc. Received Nasdaq Notification Regarding Minimum Market Value Deficiency
NaaS' ability to protect and enforce its intellectual property rights; NaaS' ability to attract and retain qualified executives and personnel; the COVID-19 pandemic and the effects of government and other measures that have been or will be taken in connection therewith; U.S.-China trade war and its effect
More news about: NaaS Technology Inc.
Feb 20, 2026, 09:08 ET Real Estate Icon Teresa King Kinney Announces Retirement Plans
During COVID, MIAMI got up and running virtually within one working day of the pandemic hitting. In-person classes were immediately shifted to Zoom. A COVID-19 resource page was posted on its website and MIAMI contracted for a new virtual tour service. MIAMI's advocacy team almost immediately successfully
More news about: MIAMI Association of REALTORS®
Feb 20, 2026, 08:31 ET Respiratory Virus Season Is Fully Active. California Greens' Immunity Can Help
an update on the state of respiratory illness in the current winter season. While COVID-19 remained low, both seasonal influenza (the flu) and RSV remain elevated in many areas.For the team at California Greens, the best option to
More news about: California Greens
Feb 20, 2026, 08:00 ET Zenocutuzumab Treatment Beyond Progression Demonstrates Continued Benefit in Patients with NRG1+ Non-Small Cell Lung Cancer: New Results from the eNRGy Trial
patients with NRG1 gene fusion positive pancreatic adenocarcinoma who received BIZENGRI.There were 2 fatal adverse reactions, one due to COVID-19 and one due to respiratory failure.In patients with NRG1 gene fusion positive pancreatic adenocarcinoma who received BIZENGRI the most
More news about: Partner Therapeutics, Inc.
Feb 20, 2026, 06:59 ET Cogent Communications Reports Fourth Quarter 2025 and Full Year 2025 Results
Wireline Business and the related costs continuing for a longer period than expected; transition related costs associated with the acquisition; the COVID-19 pandemic and the related government policies; future economic instability in the global economy, including the risk of economic recession, recent
More news about: Cogent Communications Holdings, Inc.
Feb 20, 2026, 06:22 ET First Responder Beyond Borders: Indian Navy's Humanitarian Outreach in the Indian Ocean Region
supplies, and liquid medical oxygen to countries including Maldives, Mauritius, Seychelles, Madagascar, Comoros, Sudan, and Mozambique during the COVID-19 pandemic. Over successive deployments, thousands of tonnes of essential supplies were transported to several nations. These missions were undertaken
More news about: The Indian Navy
Feb 20, 2026, 02:00 ET U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
combination with acalabrutinib are neutropenia, headache, diarrhea, musculoskeletal pain, and COVID-19. The most common serious adverse reactions (≥2%) in patients receiving V+A were COVID-19, including COVID-19 pneumonia (9%), second primary malignancies (2.7%), and neutropenia (2.1%). In patients treated
More news about: AbbVie
Feb 19, 2026, 17:00 ET RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) plus immunotherapy shows strong clinical benefit with 56 percent overall response rate in first-line recurrent or metastatic head and neck cancer
occurring in ≥2% of patients including rash, pneumonia, ILD, PE, vomiting, and COVID-19. Fatal adverse reactions occurred in 7 patients (4.6%) due to pneumonia, cerebrovascular accident, cardio-respiratory arrest, COVID-19, sepsis, and death not otherwise specified.RYBREVANT® as
More news about: Johnson & Johnson
Feb 19, 2026, 16:30 ET Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2025, Its 2026 Business Outlook, and Cash Dividend
significantly;the negative impact of public threats such as a global pandemic or widespread outbreak of an infectious disease similar to the COVID-19 pandemic;the failure of our Medicare-certified long term care hospitals or inpatient rehabilitation facilities to maintain their Medicare
More news about: Select Medical Holdings Corporation
Feb 19, 2026, 12:15 ET Patients with Crohn's disease maintained steroid-free remission for three years with Lilly's Omvoh (mirikizumab-mrkz)
reported from the end of year one through the end of year three (≥5% of Omvoh-treated patients who achieved endoscopic response at one year) included COVID-19, nasopharyngitis, and upper respiratory tract infection.1Consistently Low Rates of Severe Disease‑Related Complications in
More news about: Eli Lilly and Company
Feb 19, 2026, 09:00 ET Sibel Health Receives FDA Acceptance into Drug Development Tool Qualification Program for Innovative Cough Monitoring Sensor
report significant social and emotional impacts, including stigma, isolation, and avoidance of public settings—concerns that were amplified during the COVID-19 pandemic.Current clinical trial endpoints rely heavily on subjective patient-reported outcomes (PROs) such as patient diaries and recall-based
More news about: Sibel Health
Feb 19, 2026, 07:00 ET Mastech Digital Reports Fourth Quarter and Full-Year 2025 Results
expectations concerning its operations and operating results, the extent to which the Company's business is adversely affected by the impacts of the COVID-19 pandemic or any other health epidemics or other outbreaks that disrupt day-to-day activities and other risks that are described in more detail in
More news about: Mastech Digital, Inc.
Feb 18, 2026, 10:46 ET Advance Directives Market Poised to Surge to $510.2 Billion by 2033 at a 15.4% CAGR: Allied Market Research
systematic efforts by healthcare organizations to prioritize patient-centered care have elevated advance directives as a key part of clinical practice. The COVID-19 pandemic further surged the interest in advance care planning.Compared to previous years, the market exhibits stronger institutional support,
More news about: Allied Market Research
Feb 18, 2026, 07:30 ET RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer
occurring in ≥2% of patients including rash, pneumonia, ILD, PE, vomiting, and COVID-19. Fatal adverse reactions occurred in 7 patients (4.6%) due to pneumonia, cerebrovascular accident, cardio-respiratory arrest, COVID-19, sepsis, and death not otherwise specified.RYBREVANT® as
More news about: Johnson & Johnson
Feb 18, 2026, 07:00 ET Cepheid Selected by CDC as National Collaborator, Advancing Rapid Diagnostic Innovation to Strengthen U.S. Pandemic Preparedness
safeguard communities with advanced, high-impact testing solutions." Cepheid's legacy of rapid assay development was exemplified during the COVID-19 pandemic, when the company launched the first point-of-care PCR test for SARS-CoV-2 in the United States2 within weeks of the viral sequence
More news about: Cepheid